A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

One thing to know is that another drug called Zepbound contains the same active ingredient as Mounjaro — tirzepatide — and is FDA-approved for weight loss. Mounjaro is prescribed for those ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...